Cargando…
The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
In gastric cancer, a new epigenetic mechanism of tumour suppressor loss has been suggested where the histone methyltransferase enhancer of zeste homolog 2 (EZH2) is responsible for loss of expression of RUNX3. This is consistent with EZH2 upregulation in multiple cancer types being associated with p...
Autores principales: | Kodach, Liudmila L., Jacobs, Rutger J., Heijmans, Jarom, van Noesel, Carel J.M., Langers, Alexandra M.J., Verspaget, Hein W., Hommes, Daniel W., Offerhaus, G.Johan A., van den Brink, Gijs R., Hardwick, James C.H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930806/ https://www.ncbi.nlm.nih.gov/pubmed/20631058 http://dx.doi.org/10.1093/carcin/bgq147 |
Ejemplares similares
-
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015) -
Intestinal Tumorigenesis Is Not Affected by Progesterone Signaling in Rodent Models
por: Heijmans, Jarom, et al.
Publicado: (2011) -
Correction: Intestinal Tumorigenesis Is Not Affected by Progesterone Signaling in Rodent Models
por: Heijmans, Jarom, et al.
Publicado: (2013) -
The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
por: Voorneveld, P W, et al.
Publicado: (2015) -
Rage mediated DAMP signaling in intestinal tumorigenesis
por: Heijmans, Jarom, et al.
Publicado: (2012)